Cargando…
Selective inhibitors of nuclear export (SINE) as novel therapeutics for prostate cancer
Mislocalization of proteins is a common feature of cancer cells. Since localization of proteins is tightly linked to its function, cancer cells can inactivate function of a tumor suppressor protein through mislocalization. The nuclear exportin CRM1/XPO 1 is upregulated in many cancers. Targeting XPO...
Autores principales: | Mendonca, Janet, Sharma, Anup, Kim, Hae-Soo, Hammers, Hans, Meeker, Alan, De Marzo, Angelo, Carducci, Michael, Kauffman, Michael, Shacham, Sharon, Kachhap, Sushant |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4171616/ https://www.ncbi.nlm.nih.gov/pubmed/25026284 |
Ejemplares similares
-
A method for quantification of exportin-1 (XPO1) occupancy by Selective Inhibitor of Nuclear Export (SINE) compounds
por: Crochiere, Marsha L., et al.
Publicado: (2015) -
The prostate metastasis suppressor gene NDRG1 differentially regulates cell motility and invasion
por: Sharma, Anup, et al.
Publicado: (2017) -
Transcriptome sequencing in prostate cancer identifies inter-tumor heterogeneity
por: Mendonca, Janet, et al.
Publicado: (2015) -
XPO1/CRM1-Selective Inhibitors of Nuclear Export (SINE) reduce tumor spreading and improve overall survival in preclinical models of prostate cancer (PCa)
por: Gravina, Giovanni Luca, et al.
Publicado: (2014) -
Biologic activity of the novel orally bioavailable selective inhibitor of nuclear export (SINE) KPT-335 against canine melanoma cell lines
por: Breit, Megan N, et al.
Publicado: (2014)